Symrise (SY1) Given a €77.00 Price Target at Nord/LB
Symrise (FRA:SY1) received a €77.00 ($89.53) target price from equities research analysts at Nord/LB in a report released on Wednesday. The firm presently has a “neutral” rating on the stock. Nord/LB’s target price would indicate a potential downside of 5.68% from the stock’s previous close.
Several other research firms have also recently commented on SY1. Independent Research set a €74.00 ($86.05) target price on shares of Symrise and gave the stock a “neutral” rating in a research report on Tuesday, January 22nd. Baader Bank set a €80.00 ($93.02) target price on shares of Symrise and gave the stock a “buy” rating in a research report on Monday, December 17th. Hauck & Aufhaeuser set a €58.00 ($67.44) target price on shares of Symrise and gave the stock a “sell” rating in a research report on Wednesday, December 12th. UBS Group set a €76.00 ($88.37) target price on shares of Symrise and gave the stock a “neutral” rating in a research report on Wednesday, November 21st. Finally, Credit Suisse Group set a €84.00 ($97.67) price target on shares of Symrise and gave the company a “buy” rating in a research report on Tuesday, December 4th. Three equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and seven have issued a buy rating to the company. Symrise has a consensus rating of “Hold” and a consensus price target of €74.07 ($86.13).
FRA:SY1 opened at €81.64 ($94.93) on Wednesday. Symrise has a 12 month low of €56.96 ($66.23) and a 12 month high of €73.48 ($85.44).
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
Read More: What are the Benefits of Index Funds?
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.